Xiangping Zong

Statistics

Publications

Citations

116

H-Index

Active since

2019

Affiliations

First Affiliated Hospital of Soochow University(Current)

Soochow University

East China Normal University

Xiangping Zong is an author at First Affiliated Hospital of Soochow University specializing in hematologic malignancy car t-cell therapy, cancer immunotherapy, and immunotherapy.

Publications per year

2019–2023

Publications

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Ying Zhang, Jiaqi Li, Xiaoyan Lou et al. · Frontiers in Oncology · 2021 · 39 citations · Full text

Life Sciences, Oncology, Pharmacokinetics +17

Comparison of CAR-T19 and autologous stem cell transplantation for refractory/relapsed non-Hodgkin’s lymphoma

Caixia Li, Ying Zhang, Changfeng Zhang et al. · JCI Insight · 2019 · 28 citations · Full text

Medicine, Immunology, Oncology +16

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma

Jin Zhou, Ying Zhang, Meng Shan et al. · Frontiers in Immunology · 2022 · 24 citations · Full text

Medicine, Hematology, Oncology +15

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement

Hongzhi Geng, Sixun Jia, Ying Zhang et al. · Frontiers in Immunology · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacology +9

Tislelizumab augment the efficacy of CD19/22 dual‐targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B‐cell non‐Hodgkin lymphoma

Ying Zhang, Hongzhi Geng, Liangyu Zeng et al. · Hematological Oncology · 2023 · 12 citations

Life Sciences, Immunology, Oncology +17

1–5 of 5